Showing results (201-210 of 378) with videos related to

Sort By:
Pageof 38
Life Sciences|March 10, 2001
Effects of vasoactive intestinal peptide (VIP) and somatostatin (SST) on lipoprotein receptor expression by A431 tumor cellsS R Li, E Koller, P Valent, et al.
Thrombosis and Haemostasis|June 1, 2002
New aspects in thrombosis research: possible role of mast cells as profibrinolytic and antithrombotic cellsP Valent, M Baghestanian, H C Bankl, et al.
Wiener Klinische Wochenschrift|January 1, 1993
[New concepts in therapy of type I allergic diseases]R Valenta, P Steinberger, S Vrtala, et al.
The Journal of Investigative Dermatology|October 9, 1998
Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodiesM Ghannadan, M Baghestanian, F Wimazal, et al.
Experimental Hematology|February 24, 1998
Phenotypic and functional characterization of mast cells derived from renal tumor tissuesW J Beil, W Füreder, H Wiener, et al.
Wiener Klinische Wochenschrift|January 1, 1993
[Effector cells in allergy: biological principles and new pharmacologic concepts]W R Sperr, H Agis, R Valenta, et al.
International Archives of Allergy and Immunology|October 26, 1999
Recent advances in mastocytosis research. Summary of the Vienna Mastocytosis Meeting 1998P Valent, L Escribano, R M Parwaresch, et al.
Clinical and Experimental Immunology|May 2, 2002
IgA autoreactivity: a feature common to inflammatory bowel and connective tissue diseasesL Kazemi-Shirazi, C H Gasche, S Natter, et al.
Wiener Klinische Wochenschrift|September 29, 2000
Efficacy of standard treatment in patients with Hodgkin's disease--a single center experienceK Geissler, H Gisslinger, P Knöbl, et al.
International Archives of Allergy and Immunology|May 4, 1999
An in vitro model for the allergen-IgE-FcARI interactionS Laffer, E Hogbom, J Adrianson, et al.
Pageof 38